Detalhe da pesquisa
1.
Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trial.
Lancet
; 401(10371): 131-139, 2023 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495882
2.
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.
J Virol
; 87(9): 4907-22, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23408630
3.
Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons.
J Virol
; 83(19): 9957-69, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19605476
4.
Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization.
NPJ Vaccines
; 5(1): 26, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32218998
5.
Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues.
J Clin Microbiol
; 47(6): 1939-41, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19386844
6.
Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.
J Virol
; 80(7): 3259-72, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16537593
7.
Activation of fusion by the SER virus F protein: a low-pH-dependent paramyxovirus entry process.
J Virol
; 77(11): 6520-7, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12743308
8.
Mutations in the cytoplasmic domain of a paramyxovirus fusion glycoprotein rescue syncytium formation and eliminate the hemagglutinin-neuraminidase protein requirement for membrane fusion.
J Virol
; 77(1): 167-78, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12477822